Microemulsion utility in pharmaceuticals: Implications for multi-drug delivery

International Journal of Pharmaceutics

Volumn 526, Issue 1-2, 2017, Pages 425-442

  Callender, Shannon P ^a   Mathews, Jessica A ^a   Kobernyk, Katherine ^a   Wettig, Shawn D ^a,b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Drug delivery; Emulsions; Microemulsions; Multi drug delivery

Indexed keywords

DRUG; NONIONIC SURFACTANT; SURFACTANT; WATER OIL CREAM;

CLINICAL EFFECTIVENESS; DRUG DELIVERY SYSTEM; DRUG STABILITY; ELECTRIC CONDUCTIVITY; HEALTH ECONOMICS; HUMAN; LIPOPHILICITY; MICROEMULSION; NANOEMULSION; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; SELF CONCEPT; SELF EMULSIFYING DRUG DELIVERY SYSTEMS; TURBIDITY; VISCOSITY; CHEMISTRY; EMULSION; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; SURFACE-ACTIVE AGENTS;

EID: 85019604226     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.05.005     Document Type: Review

References (117)

1. Andreazza, A.C., Young, L.T., The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int. J. Neuropsychopharmacol., 17, 2014, 1039.
2. Anonymous Economic Burden of Illness in Canada 2005–2008. Public Health Agency of Canada 2014, 1.
3. Athyros, V.G., Katsiki, N., Karagiannis, A., Mikhailidis, D.P., Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular disease. Curr. Pharm. Des., 20, 2014, 1.
4. Attwood, D., Florence, A.T., Chapter 4: surfactants. Physical Pharmacy, vol. 2nd Edition, 2012, Pharmaceutical Press, UK, 43.
5. Atwood, J.L., Steed, J.W., Encyclopedia of Supramolecular Chemistry, vol. 2, 2004, CRC Press, USA.
6. Baboota, S., Alam, M., Sharma, S., Sahni, J., Kumar, A., Ali, J., Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis. Int. J. Pharm. Investig., 1, 2011, 139.
7. Baek, M.K., Lee, J.H., Cho, Y.H., Kim, H.H., Lee, G.W., Self-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrate: preparation and evaluation. Int. J. Nanomed. 8 (2013), 167–176.
8. Balazs, O., Preclinical formulation in early drug research. Tihanyi, K., Vastag, M., (eds.) Solubility, Delivery and ADME Problems of Drugs and Drug-Candidates, 2011, Bentham Science Publishers, 68.
9. Bancroft, W.D., The theory of emulsification. J. Phys. Chem., 17, 1913, 501.
10. Bibette, J., Calderon, F.L., Poulin, P., Emulsions: basic principles. Rep. Prog. Phys., 62, 1999, 969.
11. Brandlin, C., Your Body, Your Genes, Your Digestion, and Your Metabolism. 2013, Xlibris LLC, USA, 87.
12. Brinker, C.J., Lu, Y., Sellinger, A., Fan, H., Evaporation-induced self-assembly: nanostructures made easy. Adv. Mater., 11, 1999, 579.
13. Brown, M.E., Burlett, D.J., Chapter 19: quality control-pharmaceuticals. Gallagher, P.K., (eds.) Handbook of Thermal Analysis and Calorimetry: Recent Advances, Techniques and Applications, Vol. 5, 2011, Elsevier, UK.
14. Castanon, N., Lasselin, J., Capuron, L., Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front. Endocrinol. (Lausanne), 5, 2014, 74.
15. Cerpnjak, K., Zvonar, A., Gasperlin, M., Vrcer, F., Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm., 63, 2013, 427.
16. Chemelli, A., Maurer, M., Geier, R., Glatter, O., Optimized loading and sustained release of hydrophilic proteins from internally nanostructured particles. Langmuir, 28, 2012, 16788.
17. Cho, W., Kim, M.S., Kim, J.S., Park, J., Park, H.J., Cha, K.H., Park, J.S., Hwang, S.J., Optimized formulation of solid self-microemulsifying sirolimus delivery systems. Int. J. Nanomed., 8, 2013, 1673.
18. Clausse, M., Nicolas-Morgantini, L., Zradba, A., Touraud, D., Chapter 2: water/ionic surfactant/alkanol/hydrocarbon systems: influence of certain constitution and composition parameters on the realms of existence and transport properties of microemulsion-type media. Rosano, H.L., Clausse, M., (eds.) Microemulsion Systems, Vol. 24, 1987, Marcel Dekker Inc, NY, USA, 15.
19. Dahan, A., Hoffman, A., Chapter 6: enhanced gastrointestinal absorption of lipophilic drugs. Touitou, E., Barry, B., (eds.) Enhancement in Drug Delivery, 2011, CRC Press, USA, 111.
20. Davies, J.T., A quantitative kinetics theory of emulsion type. I. Physical chemistry of the emulsifying agent. In gas/liquid and liquid/liquid interfaces. Proceedings of the 2nd International Congress of Surface Activity, 1957, 430.
21. Deshmukh, A., Kulkarni, S., Solid self-microemulsifying drug delivery system of ritonavir. Drug Dev. Ind. Pharm., 40, 2014, 477.
22. Ding, W., Hou, X., Cong, S., Zhang, Y., Chen, M., Lei, J., Meng, Y., Li, X., Li, G., Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus. Drug Deliv., 2015, 1.
23. Dodiya, S.S., Chavhan, S.S., Sawant, K.K., Korde, A.G., Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies. J. Microencapsul., 28, 2011, 515.
24. El Maghraby, G., Arafa, M., Osman, M., Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation. Drug Dev. Ind. Pharm., 40, 2014, 1637.
25. Eriksson, J.C., Ljunggren, S., Kegel, W.K., Lekkerkerker, H.N.W., Entropy and droplet size distributions of Winsor I and II microemulsions. Colloids Surf., 183–185, 2001, 347.
26. Farrell, B., Merkley, V.F., Ingar, N., Reducing pill burden and helping with medication awareness to improve adherence. CPJ/RPC, 146, 2013, 262.
27. Fast, J., Mecozzi, S., Chapter 15: nanoemulsions for intravenous drug delivery. de Villiers, M.M., Aramwit, P., Kwon, G.S., (eds.) Nanotechnology in Drug Delivery, vol. X, 2009, American Association of Pharmaceutical Scientists Press, USA, 461.
28. Fisher, S., Wachtel, E., Aserin, A., Garti, N., Solubilization of simvastatin and phytosterols in a dilutable microemulsion system. Colloids Surf. B: Biointerfaces, 107, 2013, 35.
29. Fleeman, N., Bagust, A., Boland, A., Dickson, R., Dundar, Y., Moonan, M., Oyee, J., Blundell, M., Davis, H., Armstrong, A., Thorp, N., Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis. Health Technol. Assess., 2011, 15.
30. Fletcher, P.D.I., Morris, J.S., Turbidity of oil-in-water microemulsion droplets stabilized by nonionic surfactants. Colloids Surf., 98, 1995, 147.
31. Fletcher, P.D., I: interfacial tension between microemulsion and excess dispersed phases. Chem. Phys. Lett., 141, 1987, 357.
32. Floyd, R.A., Neto, H.C.C.F., Zimmerman, G.A., Hensley, K., Towner, R.A., Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines. Free Radic. Biol. Med., 62, 2013, 145.
33. Gao, Z., Choi, H., Shin, H., Park, K., Lim, S., Hwang, K., Kim, C., Physicochemical characterization and evaluation of a microemulsion system for oral deliery of cyclosporin A. Int. J. Pharm., 161, 1998, 75.
34. Gibaud, S., Attivi, D., Microemulsions for oral administration and their therapeutic applications. Expert Opin. Drug Deliv., 9, 2012, 937.
35. Grill, A.E., Koniar, B., Panyan, J., Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin. Drug Deliv. Transl. Res., 4, 2014, 344.
36. Grove, M., Mullertz, A., Hauss, D.J., (eds.) Oral Lipid Based Formulations- Enhancing the Bioavailability of Poorly Water Soluble Drugs. Chapter 5-Liquid Self-Microemulsifying Drug Delivery Systems, vol. 170, 2007, Drugs and the Pharmaceutical Sciences, Informa Healthcare, USA.
37. Gullapalli, R.P., Soft gelatin capsules. J. Pharm Sci, 99, 2010, 4107.
38. Gupta, S., Kesarla, R., Omri, A., Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm., 2013, 1.
39. Gupta, S., Bansal, R., Ali, J., Gabrani, R., Dang, S., Development and characterization of polyphenon 60 and caffeine microemulsion for enhanced antibacterial activity. Boomed. Res. Int., 2014, 1.
40. Hajjar, I., Quach, L., Yang, F., Chaves, P.H.M., Newman, A.B., Mukamal, K., Longstreth, W. Jr., Inzitari, M., Lipsitz, L.A., Hypertension, white matter hyperintensities and concurrent impairments in mobility, cognition and mood: the Cardiovascular Health Study. Circulation, 123, 2011, 858.
41. Hauss, D.J., Oral lipid-based formulations. Adv. Drug Deliv. Rev., 59, 2007, 667.
42. He, C., He, Z., Gao, J., Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs. Expert Opin. Drug Deliv., 7, 2010, 445.
43. Hintzen, F., Perera, G., Hauptstein, S., Müller, C., Laffleur, F., Bernkop-Schnürch, A., In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int. J. Pharm., 472, 2014, 20.
44. Hu, L., Wu, H., Niu, F., Yan, C., Yang, X., Jia, Y., Design of fenofibrate microemulsion for improved bioavailability. Int. J. Pharm., 420, 2011, 251.
45. Huh, C., Interfacial tensions and solubilizing ability of a microemulsion phase that coexists with oil and brine. J. Colloid Interface Sci. 71 (1979), 408–426.
46. Hwang, K., Park, S., Kim, J., Park, C., Rhee, Y., Park, E., Formulation and in vitro evaluation of self-microemulsifying drug delivery system containing fixed-dose combination of atorvastatin and ezetimibe. Chem. Pharm. Bull., 63, 2015, 423.
47. Innala, L., Sjöberg, C., Möller, B., Ljung, L., Smedby, T., Södergren, A., Magnusson, S., Rantapää-Dahlqvist, S., Wållberg-Jonsson, S., Co-morbidity in patients with early rheumatoid arthritis-inflammation matters. Arthritis Res. Ther., 18, 2016, 1.
48. Jala, R.C.R., Prasad, R.B.N., Chapter 2: rice bran lecithin: compositional, nutritional and functional characteristics. Ahmad, M.U., Xu, X., (eds.) Polar Lipids: Biology, Chemistry, and Technology, 2015, AOCS Press, USA, 35.
49. Jambhekar, S.S., Breen, P.J., Drug dissolution: significance of physicochemical properties and physiological conditions. Drug Discov. Today, 18, 2013, 1173.
50. Jin, J., Sklar, G.E., Oh, V.M.S., Li, S.C., Factors affecting therapeutic compliance: a review from the patient's perspective. Ther. Clin. Risk Manage., 4, 2008, 269.
51. Kahlweit, M., Busse, G., Winkler, J., Electric conductivity in microemulsions. J. Chem. Phys., 99, 1993, 5605.
52. Kalam, M.A., Alshamsan, A., Aljuffali, I.A., Mishra, A.K., Sultana, Y., Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination. Drug Deliv., 23, 2016, 896.
53. Kamboj, S., Sharma, R., Singh, K., Rana, V., Aprepitant loaded solid pre-concentrated microemulsion for enhanced bioavailability: a comparison with micronized Aprepitant. Eur. J. Pharm. Sci. 78 (2015), 90–102.
54. Kamranfar, P., Jamialahmadi, M., Effect of surfactant micelle shape transition on the microemulsion viscosity and its application in enhanced oil recovery process. J. Mol. Liq., 198, 2014, 286.
55. Katsareli, E.A., Dedoussis, G.V., Biomarkers in the field of obesity and its related comorbidities. Expert Opin. Ther. Targets, 18, 2014, 385.
56. Kaur, G., Mehta, S., Probing location of anti-TB drugs loaded in brij 96 microemulsions using thermoanalytical and photophysical approach. J. Pharm. Sci., 103, 2014, 937.
57. Klump, H.H., Chapter 1: energetics that control the stability and dynamics of secondary and tertiary structure of nucleic acids. Kemp, R.B., Gallagher, P.K., (eds.) Handbook of Thermal Analysis and Calorimetry: From Macromolecules to Man, Vol. 4, 1999, Elsevier, The Netherlands, 9.
58. Kwon, Y., Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists, Chapter 4: Absorption. 2002, Kleuwer Academic Publishers, USA, 35.
59. Lang, J., Lalem, N., Zana, R., Droplet size and dynamics in water-in-oil microemulsions. Colloids Surf., 68, 1992, 199.
60. Langevin, D., Guest, D., Meunier, J., Correlation between interfacial tension and microemulsion structure in winsor equilibria: role of the surfactant film curvature properties. Colloids Surf., 19, 1986, 159.
61. Langevin, D., Microemulsions. Acc. Chem. Res., 21, 1988, 255.
62. Lawrence, M.J., Warisnoicharoen, W., Chapter 7: recent advances in microemulsions as drug delivery vehicles. Torchillin, V., (eds.) Nanoparticulates as Drug Carriers, 2006, Imperial College Press, UK.
63. Leal-Calderon, F., Schmitt, V., Bibette, J., Emulsion Science: Basic Principles. 2007, Springer Science and Business Media, Paris, France.
64. Lee, J., Ma, S., Heng, D., Chew, S.K., Hughes, K., Tai, E.S., Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study. J. Hum. Hypertens., 22, 2008, 468.
65. Lee, H.Y., Sakuma, I., Ihm, S.H., Goh, C.W., Koh, K.K., Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease. Circ. J., 78, 2014, 281.
66. Lee, S., Rothbard, A., Choi, S., Effects of comorbid health conditions on healthcare expenditures among people with severe mental illness. J. Ment. Health, 2015, 1.
67. Li, Q., Zhai, W., Jiang, Q., Huang, R., Liu, L., Dai, J., Gong, W., Du, S., Wu, Q., Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. Int. J. Pharm., 490, 2015, 22.
68. Linton, S.S., Sherwood, S.G., Drews, K.C., Kester, M., Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine. Nanomed. Nanobiotechnol., 8, 2016, 208.
69. Liu, R., Dannenfelser, R.M., Li, S., Chapter 12: micellization and drug solubility enhancement. Liu, R., (eds.) Water-Insoluble Drug Formulation, vol. 2nd Edition, 2008, CRC Press, USA pg 296.
70. Liu, W., Zhai, Y., Heng, X., Che, F., Chen, W., Sun, D., Zhai, G., Oral bioavailability of curcumin: problems and advancements. J. Drug Target., 2016, 1.
71. Malmsten, M., Chapter 5: microemulsions in pharmaceuticals. Kumar, P., Mittal, K.L., (eds.) Handbook of Microemulsion Science and Technology, 1999, Marcel Dekker Inc, USA, 755.
72. Martin-Rodriguez, E., Guillen-Grima, F., Martí, A., Brugos-Larumbe, A., Comorbidity associated with obesity in a large population: the APNA study. Obes. Res. Clin. Pract., 9, 2015, 435.
73. Mason, T.G., Wilking, J.N., Meleson, K., Chang, C.B., Graves, S.M., Nanoemulsions Formation, structure, and physical properties. J. Phys. Condens. Matter, 18, 2006, R635.
74. McClements, D.J., Nanoemulsions versus microemulsions: terminology, differences and similarities. Soft Matter, 8, 2012, 1719.
75. McClements, D.J., Nanoscale nutrient delivery systems for food applications: improving bioactive dispersibility, stability, and bioavailability. J. Food Sci., 80, 2015, 1602.
76. McCuistion, L.E., Kee, J., Hayes, E.R., Pharmacology: A Patient-Centered Nursing Process Approach (8 Ed.), Chapter 1: Drug Action: Pharmaceutic, Pharmacokinetic and Pharmacodynamic Phases. 2014, Elsevier Saunders, USA.
77. Mehta, S.K., Kaur, G., Chapter 18: Microemulsions: thermodynamic and dynamic properties. Tadashi, M., (eds.) Thermodynamics, 2011, InTech, 381.
78. Michaud, K., Wolfe, F., Comorbidities in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol., 21, 2007, 885.
79. Myers, D., Chapter 2:The organic chemistry of surfactants. Surfactant Science and Technology, vol. 3rd edition, 2005, Wiley Interscience, USA, 29.
80. Nave, S., Estoe, J., What is so special about aerosol-OT? 1. Aqueous systems. Langmuir, 16, 2000, 8733.
81. Negi, P., Singh, B., Sharma, G., Beg, S., Raza, K., Katare, O., Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation. Drug Deliv., 23, 2016, 941.
82. Ngan, C.L., Basri, M., Tripathy, M., Karjiban, R.A., Abdul-Malek, E., Physicochemical characterization and thermodynamic studies of nanoemulsion-Based transdermal delivery system for fullerene. Sci. World J., 2014, 1.
83. Niazi, S.K., Handbook of Bioequivalence Testing, Chapter 3: Drug Delivery Factors, vol. 2nd Edition, 2015, CRC Press, USA.
84. Nousen, E.K., Franco, J.G., Sullivan, E.L., Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders. Neuroendocrinology, 98, 2013, 254.
85. Ogdie, A., Schwartzman, S., Eder, L., Maharaj, A., Zisman, D., Raychaudhuri, S., Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations. J. Rheumatol., 41, 2014, 2315.
86. Osmun, W.E., Kim, G.P., Harrison, E.R., Patients with multiple comorbidities: simple teaching strategy. Can. Fam. Phys., 2015, 61.
87. Ostrovsky, M.V., Good, R.J., Mechanism of microemulsion formation in systems with low interfacial tension: occurrence, properties and behaviour of microemulsions. J. Colloid Interface Sci., 102, 1984, 206.
88. Paradkar, A.R., Bakliwal, S., Chapter 2: drug absorption. Biopharmaceutics & Pharmacokinetics, vol. 3rd Ed, 2008, Nirali Prakashan, India pp 2.16.
89. Pasina, L., Brucato, A.L., Falcone, C., Cucchi, E., Bresciani, A., Sottocorno, M., Taddei, G.C., Casati, M., Franchi, C., Djade, C.D., Nobili, A., Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging, 31, 2014, 283.
90. Pepe, D., Phelps, J., Lewis, K., DuJack, J., Scarlett, K., Jahan, S., Bonnier, E., Milic-Pasetto, T., Hass, M., Lopes, L., Decylglucoside-based microemulsions for cutaneous localization of lycopene and ascorbic acid. Int. J. Pharm., 434, 2012, 420.
91. Phan, T.T., Attaphong, C., Sabatini, D.A., Effect of extended surfactant structure on interfacial tension and microemulsion formation with triglycerides. J. Am. Oil Chem. Soc., 88, 2011, 1223.
92. Pouchelon, A., Chatenay, D., Meunier, J., Langevin, D., Origin of low interfacial tensions in systems involving microemulsion phases. J. Colloid Interface Sci., 82, 1981, 418.
93. Prince, L.M., Microemulsions Theory and Practice. 1977, Elsevier, 21.
94. Qu, D., Ma, Y., Sun, W., Chen, Y., Zhou, J., Liu, C., Huang, M., Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells. Int. J. Nanomed., 10, 2015, 1173.
95. Rahman, M.A., Hussain, A., Hussain, M.S., Mirza, M.A., Iqbal, Z., Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev. Ind. Pharm., 39, 2013, 1.
96. Ramli, S., Ross, B.P., Gentle, I.R., Formulation and physical characterization of microemulsions containing isotretinoin. International Conference on Biomedical and Pharmaceutical Engineering, 2009, 1.
97. Chapter 8: emulsification by surfactants. Rosen, M.J., Kunjappu, J.T., (eds.) Surfactants and Interfacial Phenomena, 4th edition, 2012, John Wiley & Sons Publisher, New Jersey, USA, 336.
98. Rozentur, E., Nassar, T., Benita, S., Chapter 12: materials for nanoemulsions and their influence on the biofate. Torchillin, V., Amiji, M.M., (eds.) Handbook of Materials for Nanomedicine, 2010, Pan Stanford Publishing Pte. Ltd, Singapore, 515.
99. Ruckenstein, E., Phase behaviour of microemulsions: derivation of expressions for the natural radius and for the interfacial tension between microemulsion and the excess dispersed phase. Chem. Phys. Lett., 118, 1985, 435.
100. Sajatovic, M., Gunzler, D., Einstadter, D., Thomas, C., McCormick, R., Perzynski, A.T., Kanuch, S., Cassidy, K.A., Blixen, C., A preliminary analysis of individuals with serious mental illness and comorbid diabetes. Arch. Psychiatr. Nurs., 30, 2016, 226.
101. Salager, J.L., Morgan, J.C., Schechter, R.S., Wade, W.H., Vasquez, E., Optimum formulation of surfactant/water/oil systems for minimum interfacial tension or phase behavior. Soc. Petrol. Eng. J., 1979, 107.
102. Salager, J.L., Anton, R.E., Sabatini, D.A., Harwell, J.H., Acosta, E.J., Tolosa, E.I., Enhancing solubilization in microemulsions: state of the art and current trends. J. Surf. Det., 8, 2008, 3.
103. Sepeur, S., Nanotechnology: Basics and Applications. 2008, Vincentz Network, Germany, 59.
104. Shah, L.K., Amiji, M.M., Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS. Pharm. Res., 23, 2006, 2638.
105. Shargel, L., Wu-Pong, S., Yu, A.B.C., Applied Biopharmaceutics & Pharmacokinetics, Chapter 14. Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance. vol. 6th edition, 2012, McGraw-Hill Education, USA.
106. Shi, J., Cong, W., Wang, Y., Liu, Q., Luo, G., Microemulsion-based patch for transdermal delivery of huperzine A and ligustrazine phosphate in treatment of Alzheimer's disease. Drug Dev. Ind. Pharm., 38, 2012, 752.
107. Shinde, R., Bharkad, G., Devarajan, P., Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: role of docosahexaenoic acid. Eur. J. Pharm. Biopharm., 96, 2015, 363.
108. Tadros, T.F., Chapter 2: physical chemistry of surfactant solutions. Applied Surfactants: Principles and Applications, 2005, Wiley-VCH, UK, 19.
109. Talegaonkar, S., Negi, L.M., Chapter 14: nanoemulsion in drug targeting. Devarajan, P., Jain, S., (eds.) Targeted Drug Delivery: Concepts and Design, 2015, Springer, London, UK, 433.
110. Tong, K., Zhao, C., Sun, Z., Sun, D., Formation of concentrated nanoemulsion by W/O microemulsion dilution method: biodiesel, tween 80, and water system. ACS Sustain. Chem. Eng., 3, 2015, 3299.
111. Tongcumpou, C., Acosta, E.J., Quencer, L.B., Joseph, A.F., Scamehorn, J.F., Sabatini, D.A., Chavadej, S., Yanumeta, N., Microemulsion formation and detergency with oily soils: I: phase behavior and interfacial tension. J. Surf. Deterg. 6 (2003), 191–203.
112. Ujhelyi, Z., Kalantari, A., Vecsernyes, M., Roka, E., Fenyvesi, F., Poka, R., Kozma, B., Bacskay, I., The enhanced inhibitory effect of different antitumor agents in self-microemulsifying drug delivery systems on human cervical cancer HeLa cells. Molecules, 20, 2015, 13226.
113. Uutela, T., Kautiainen, H., Järvenpää, S., Salomaa, S., Hakala, M., Häkkinen, A., Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990. Scand. J. Rheumatol., 44, 2014, 173.
114. Winsor, P.A., Hydrotropy, solubilisation and related emulsification processes. Trans. Faraday Soc. 44 (1948), 376–398.
115. Xu, M., Yu, Q., Zhao, Q., Chen, W., Lin, Y., Jin, Y., Development and in vitro-in vivo evaluation of a water-in-oil microemulsion formulation for the oral delivery of troxerutin. Drug Dev. Ind. Pharm., 42, 2016, 280.
116. Yusuf, S., Attaran, A., Bosch, J., Joseph, P., Lonn, E., McCready, T., Mente, A., Nieuwlaat, R., Pais, P., Rodgers, A., Schwalm, J.D., Smith, R., Teo, K., Xavier, D., Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. Eur. Heart J., 35, 2014, 353.
117. Zhang, Y., Zhao, J., Zhong, S., Zhong, Y., Wang, Z., Liu, Y., Shi, F., Feng, N., Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion. Int. J. Nanomed., 6, 2011, 2469.